Extended-Spectrum-Beta-Lactamases, AmpC Beta-Lactamases and Plasmid Mediated Quinolone Resistance in Klebsiella spp. from Companion Animals in Italy by Donati, Valentina et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 17, 2017
Extended-Spectrum-Beta-Lactamases, AmpC Beta-Lactamases and Plasmid Mediated
Quinolone Resistance in Klebsiella spp. from Companion Animals in Italy
Donati, Valentina; Feltrin, Fabiola; Hendriksen, Rene S.; Svendsen, Christina Aaby; Cordaro, Gessica;
Garcia-Fernandez, Aurora; Lorenzetti, Serena; Lorenzetti, Raniero; Battisti, Antonio; Franco, Alessia
Published in:
PLOS ONE
Link to article, DOI:
10.1371/journal.pone.0090564
Publication date:
2014
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
Donati, V., Feltrin, F., Hendriksen, R. S., Svendsen, C. A., Cordaro, G., Garcia-Fernandez, A., ... Franco, A.
(2014). Extended-Spectrum-Beta-Lactamases, AmpC Beta-Lactamases and Plasmid Mediated Quinolone
Resistance in Klebsiella spp. from Companion Animals in Italy. PLOS ONE, 9(3), [e90564]. DOI:
10.1371/journal.pone.0090564
Extended-Spectrum-Beta-Lactamases, AmpC Beta-
Lactamases and Plasmid Mediated Quinolone Resistance
in Klebsiella spp. from Companion Animals in Italy
Valentina Donati1, Fabiola Feltrin1, Rene S. Hendriksen2, Christina Aaby Svendsen2, Gessica Cordaro1,
Aurora Garcı´a-Ferna´ndez3, Serena Lorenzetti1, Raniero Lorenzetti1, Antonio Battisti1*, Alessia Franco1
1 Istituto Zooprofilattico Sperimentale delle Regioni Lazio e Toscana, Rome, Italy, 2 Technical University of Denmark, National Food Institute (DTU-Food), Kongens Lyngby,
Denmark, 3 Istituto Superiore di Sanita`, Department of Infectious, Parasitic and Immune-Mediated Diseases, Rome, Italy
Abstract
We report the genetic characterization of 15 Klebsiella pneumoniae (KP) and 4 isolates of K. oxytoca (KO) from clinical cases in
dogs and cats and showing extended-spectrum cephalosporin (ESC) resistance. Extended spectrum beta-lactamase (ESBL)
and AmpC genes, plasmid-mediated quinolone resistance (PMQR) and co-resistances were investigated. Among KP isolates,
ST101 clone was predominant (8/15, 53%), followed by ST15 (4/15, 27%). ST11 and ST340, belonging to Clonal Complex
(CC)11, were detected in 2012 (3/15, 20%). MLST on KP isolates corresponded well with PFGE results, with 11 different PFGE
patterns observed, including two clusters of two (ST340) and four (ST101) indistinguishable isolates, respectively. All isolates
harbored at least one ESBL or AmpC gene, all carried on transferable plasmids (IncR, IncFII, IncI1, IncN), and 16/19 were
positive for PMQR genes (qnr family or aac(69)-Ib-cr). The most frequent ESBL was CTX-M-15 (11/19, 58%), detected in all KP
ST101, in one KP ST15 and in both KP ST340. blaCTX-M-15 was carried on IncR plasmids in all but one KP isolate. All KP ST15
isolates harbored different ESC resistance genes and different plasmids, and presented the non-transferable blaSHV-28 gene,
in association with blaCTX-M-15, blaCTX-M-1 (on IncR, or on IncN), blaSHV-2a (on IncR) or blaCMY-2 genes (on IncI1). KO isolates
were positive for blaCTX-M-9 gene (on IncHI2), or for the blaSHV-12 and blaDHA-1 genes (on IncL/M). They were all positive for
qnr genes, and one also for the aac(69)-Ib-cr gene. All Klebsiella isolates showed multiresistance towards aminoglycosides,
sulfonamides, tetracyclines, trimethoprim and amphenicols, mediated by strA/B, aadA2, aadB, ant (2")-Ia, aac(69)-Ib, sul, tet,
dfr and cat genes in various combinations. The emergence in pets of multidrug-resistant Klebsiella with ESBL, AmpC and
PMQR determinants, poses further and serious challenges in companion animal therapy and raise concerns for possible bi-
directional transmission between pets and humans, especially at household level.
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Introduction
Klebsiella are bacterial pathogens that can cause a variety of
severe infections in humans, mainly due to K. pneumoniae (KP) [1],
[2] and to a lesser degree to K. oxytoca (KO) [3], [4]. KP is also a
well-known causal agent of mastitis in cattle and bacteraemia in
calves, cervicitis and metritis in mares, pneumonia and septicemia
in foals, pneumonia, urinary tract infection (UTI) and septicemia
in dogs [5], [6], [7].
Increasing antimicrobial resistance, especially towards amino-
glycosides, (fluoro)quinolones, third and fourth generation ceph-
alosporins, cephamycins, and carbapenems have been reported in
the last decade [8], [9], [10], and poses serious therapeutic
problems when treating Klebsiella infections in humans. In
veterinary medicine, scarce information is reported on the
occurrence of extended spectrum beta-lactamases (ESBLs), AmpC
beta-lactamases and plasmid mediated quinolone resistance
(PMQR) in Klebsiella isolates from companion animals [11], [12].
The aim of the study was to provide molecular characterization
of extended-spectrum cephalosporin (ESC) resistance and PMQR
in Klebsiella isolates from clinical cases or lesions in necropsied
animals of canine and feline origin in Italy. A further aim was to
determine phenotype and genotype of co-resistances, and to
provide plasmid identification and genetic relatedness by Multi-
locus Sequence Typing (MLST) and Pulsed Field Gel Electro-
phoresis (PFGE) among the isolates, to evaluate potential
clustering of ESC, PMQR, and other resistance genes among
clones.
Materials and Methods
Origin of ESC-resistant Klebsiella
Between 2006 and 2012, the Istituto Zooprofilattico Sperimen-
tale delle Regioni Lazio e Toscana (IZSLT) investigated samples
from 1555 dogs and 429 cats of clinical cases and necropsy
specimens with suspicious bacterial infections, submitted by
veterinarians practising mainly in central Italy, and some
practising in northern Italy. Presumptive positive Klebsiella isolates
were identified using the API 20E identification system (bioMe´r-
ieux, Craponne, France). For species-level identification of isolates
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e90564
with phenotypic inconclusive results 16S rDNA sequencing
technique was employed, by means of the MicroSeq Full Gene
system (Applied Biosystems, USA) as described previously [13].
Genotypic characterization
Multilocus Sequence Typing on KP isolates was performed as
previously described [14], and interpreted according to the KP
MLST database (www.pasteur.fr/mlst).
In addition, all isolates were genotyped by PFGE using XbaI
according to the previously published protocol [15].
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed as minimum
inhibitory concentrations (MIC) by micro-broth dilution in 96-well
microtitre plates (Trek Diagnostic Systems, Westlake, OH, USA).
The following antimicrobials were tested: ampicillin, cefotaxime,
ceftazidime, ciprofloxacin, chloramphenicol, florfenicol, gentami-
cin, kanamycin, nalidixic acid, streptomycin, sulfonamides,
tetracycline, and trimethoprim. The results were interpreted
according to the European Committee on Antibiotic Susceptibility
Testing (EUCAST) epidemiological cut-offs (www.eucast.org) and
to Clinical Laboratory Standard Institute [16] or EUCAST
clinical breakpoints for those drugs for which epidemiological cut-
offs have not been made available (kanamycin, chloramphenicol,
sulfamethoxazole, trimethoprim). For streptomycin, a cut-off of
16 mg/L was used, according to EUCAST MIC distributions.
Confirmatory test for the detection of ESBLs were performed
on isolates resistant to cefotaxime or ceftazidime according to
Clinical Laboratory Standard Institute (CLSI) recommendations
[16].
Detection of genes encoding beta-lactamase and PMQR
For the confirmed ESBL producing isolates, the encoding genes
belonging to the beta-lactamase and PMQR families were further
analyzed for the presence of blaCTX-M [17], blaSHV [18], blaTEM
[19], blaOXA [20], blaAmpC families [21], as well as for genes of the
qnr family, qep-A, and aac(69)-Ib-cr encoding for PMQR [22], [23],
[24], [25], [26]. The isolates were further screened by PCR for
genes encoding carbapenemases [27]. Amplicons were sequenced
by BigDye Terminator chemistry (Applied Biosystems, Foster City,
CA, USA) and migrated with an automated sequencer (ABI Prism
310; Applied Biosystems). Sequence data analysis was performed
using CLC DNA workbench software version 5.7.1 (CLC Bio,
Aarhus, Denmark) and evaluated against the GenBank nucleotide
databases.
Detection of plasmid replicons
Identification of plasmids was performed by PCR-based
replicon typing as previously described [28], [29], [30], and using
the PBRT kit (Diatheva, Fano, Italy).
Plasmid analysis
Plasmid DNA preparations were performed using the NucleoS-
pin Plasmid/Plasmid (NoLid) kit (Macherey-Nagel, Du¨ren,
Deutschland) and used to transform MAX Efficiency DH5a
Competent Cells (Invitrogen, Life Technologies, U.S.A). In order
to identify the plasmid carrying the ESBLs and AmpC genes, the
selection of the transformants was performed on LB agar plates
containing 100 mg/ml ampicillin.
Additionally, the isolates were tested according to the manu-
facturer’s instructions using an array hybridization kit for DNA-
based detection of the most common resistance genes, and for the
integrase gene (intI1) of class 1 integrons of Gram negative bacteria
(Alere Technologies GmbH, Jena, Germany) and the results
interpreted by the ArrayMate, Alere.
Results
Isolation rates
The samples (n = 1984; dogs and cats) yielded a total 70 (3.53%,
95% CI: 2.72%–4.34%) KP and 23 (1.16%, 95% CI: 0.69%–
1.63%) KO among the isolates, respectively. Of these, 15 (21.4%)
KP and four (17.4%) KO revealed resistance to ESC and were
investigated in this study.
Genetic relatedness
The 15 KP isolates investigated by MLST were assigned to four
different Sequence Types (ST): ST11 (n = 1), ST340 (n = 2),
ST101 (n = 8), and ST15 (n = 4) (Figure 1). ST11 and its single-
locus (tonB) variant (SLV) ST340 (3/15, 20%), both belonging to
CC11, were detected in 2012. The separation of the isolates based
on MLST corresponded well with PFGE results grouping the same
isolates (Figure 1). A total of 11 different PFGE patterns were
observed including two clusters of two and four indistinguishable
isolates, respectively (Figure 1). The cluster of the two isolates both
belonged to ST340 and was related (80% similarity) to a single
isolate exhibiting a unique PFGE pattern and belonging to ST11.
The other cluster of four indistinguishable isolates was highly
related (from 99% to 80% similarity) to additional four isolates
within the same PFGE group, all belonging to ST101 (Figure 1).
No clustering was observed related to time, animal origin, nor
infection, but some to the presence of resistance genes (Table 1).
No MLST was assigned to the four KO isolates. However, the four
isolates revealed three different PFGE patterns of which one was a
cluster of two identical isolates (Figure 2). The three patterns
seemed not to be related, indicating a similarity of 45% and 55%
to the pattern of the two clustering isolates. Interestingly, the two
isolates of the same PFGE pattern were both from dogs and
isolated within the same year, but it could be the result of a
random effect (Figure 2).
Antimicrobial susceptibility testing
All isolates showed microbiological resistance to third-genera-
tion cephalosporins, and also clinical resistance, either when the
MIC results were interpreted according to clinical breakpoints set
by CLSI [16] or by EUCAST (e. g. MIC cefotaxime .= 4mg/L),
except for 9KP (MIC 1 mg/L). The phenotype for PMQR was
evident (ciprofloxacin MIC 0.25mg/L, nalidixic acid 8 mg/L) in
KO isolates only, because in all KP isolates it was masked by
concurrent genetic background conferring MICs of 8 and
128 mg/L, respectively.
Moreover, all isolates showed multidrug-resistance towards
other classes of antimicrobials, such as aminoglycosides, sulfon-
amides, tetracyclines, dihydrofolate reductase inhibitors and
amphenicols, mediated by strA/B, aadA2, aadB, ant (2")-Ia,
aac(69)-Ib, sul, tet, dfr and cat genes in various combinations, as
reported in Table 1.
Genes encoding ESBL-, AmpC-, and PMQR
All Klebsiella isolates investigated showed the presence of at least
one ESBL or AmpC gene encoding ESC resistance. Additionally,
16 out of 19 isolates harbored a PMQR gene (qnr family or aac(69)-
Ib-cr, single or in combination). The most frequent ESC gene
harbored by KP isolates was blaCTX-M-15 (n = 11, 58%), detected in
all eight ST101, in one ST15 and in both two ST340 isolates,
respectively. All four ST15 KP isolates carried the blaSHV-28 gene,
single or in combination with the ESC resistance genes blaCTX-M-15,
MDR Klebsiella in Companion Animals, Italy
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blaCTX-M-1, blaCMY-2, or with the blaTEM-1. All ST101 KP isolates
harbored the variant of the aac(69)-Ib-cr gene, encoding for PMQR.
Similarly, the ST340 and ST11 KP isolates were the only ESC-
resistant KP harboring genes within the qnr family.
The ST15, ST101 and ST340 KP isolates presented the blaCTX-
M-15 gene, which was mostly associated with the blaTEM-1, blaOXA-1
and aac(69)-Ib-cr genes, and to the blaSHV-1, or blaSHV-11 or blaSHV-
28 (Table 1).
Of the four KO isolates, two were positive for blaCTX-M-9 gene,
both associated with the PMQR gene qnrA1, with one the two also
positive for the aac(69)-Ib-cr gene. The last two KO isolates
exhibited the blaSHV-12, blaTEM-1, blaDHA-1 and qnrB4 genes. All
isolates under study were negative for the presence of carbape-
nemase genes.
Plasmid analysis
Plasmids detected from all the strains and classified by the PCR-
based replicon typing method, are reported in Table 1.
In our study, the blaCTX-M-15 gene was successfully transferred
by transformation from several MLST prototypic strains, demon-
strating its plasmid localization. All but one transformant strains
were positive for plasmids belonging to the IncR incompatibility
group, and in the 18KP transconjugant the blaCTX-M-15 gene was
co-transferred with the blaDHA-1 gene. Other ST15 KP strains also
presented the IncR plasmid carrying different ESBL genes such as
blaSHV-2a and blaCTX-M-1. The 2KP ST15 strain harbored a IncI1
plasmid carrying the blaCMY-2 gene, while a IncN plasmid carrying
both the blaCTX-M-1 and qnrS1 gene was detected in the ST11
16KP strain.
The KO transformants carried the ESBL genes, blaCTX-M-9 and
blaSHV-12 in two incompatibility groups, IncHI2 and IncL/M,
respectively (Table 1).
Discussion
The paper provides evidence of heterogeneity of determinants
conferring ESC resistance in clinical Klebsiella isolates from dogs
and cats in Italy. To the best of our knowledge, all the ESC
resistant Klebsiella investigated were from sporadic clinical cases,
although two clusters of KO (n = 2) and KP ST101 (n = 4) showed
100% similarity. Apparently, isolates were epidemiologically
unrelated, with the exception of 6KP and 1KP (both ST101),
with a DNA restriction profile showing 80% similarity, isolated
from two cases of necropsies requested by the same veterinary
practitioner in 2010 and 2011, respectively.
We also document the novel finding of the co-existence of the
ESBL blaSHV-28 and the AmpC blaCMY-2 gene in one KP ST15
isolate from a cat and the first report of qnrS- and qnrA- and aac(69)-
Ib-cr- PMQR associated with Klebsiella infections in companion
animals from Europe. Klebsiella with ESBL phenotype were
described in dogs and cats from China [12], although it was
mediated in those isolates by the presence of the CTX-M-9 and
CTX-M-1 group beta-lactamases, while a CTX-M-15 positive
ST15 KP clone was reported from hospital-acquired infections in
pets from France [31]. In our study, the ESBL gene blaCTX-M-15
accounts for the majority of CTX-M genes detected in KP, but it
was harbored mainly by the predominant KP ST101 lineage.
Interestingly, all KP ST15 isolates showed the association of the
blaCTX-M-15, blaCTX-M-1, or blaCMY-2 genes with the blaSHV-28 gene,
a blaSHV-1 mutant detected for the first time in China in 2002
(GenBank AF538324), and previously reported to encode for an
ESBL phenotype [32]. Co-presence of blaCTX-M-15 and blaSHV-28
has been reported for the first time in the human KP ST15
epidemic clone by Nielsen et al., in 2011 [33]. Our transformation
experiments did not succeed in transferring any of the blaSHV28
genes from positive KP isolates.
The multidrug-resistant CTX-M-15-producing KP isolates are
an of important concern in the nosocomial infections and the
IncFII-type plasmid is the main vehicle of blaCTX-M-15 transmission
in human isolates [34]. However, in our study, this ESBL in KP
from pets was mostly carried by IncR plasmids. The association of
blaCTX-M-15 -IncR replicons in KP was documented for the first
time by Coelho et al. in 2010 [35], in human clinical isolates, and
also reported in the KP clone causing hospital-acquired infections
in pets in France [31], and in Spain, associated to qnrB4, blaDHA-1
and armA genes. [36]
Interestingly, the 17KP transformant only presented the blaCTX-
M-15 gene and the qnrS1 gene both located in a IncFII plasmid. In
our study, almost all the blaCTX-M-15 – positive isolates were also
positive for IncFIIk replicons: although they have been specifically
described in KP [30], these plasmids were never transferred in our
experiments. Interestingly, in 2012 we have reported for the first
Figure 1. Dendrogram showing the genotypic relatedness of ESC-resistant Klebsiella pneumoniae (KP) isolates from dogs and cats
based on XbaI-PFGE fingerprints, and comparison with Multilocus Sequence Typing classification.
doi:10.1371/journal.pone.0090564.g001
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time in clinical cases of pets from Italy the clone KP ST11 and its
SLV ST340, harboring ESC and qnrS1-PMQR resistance. Among
these CC11 isolates, the ST11 harbored IncN plasmid, which has
been frequently involved in the transmission of the blaCTX-M-1
gene, a feature suggesting an animal reservoir for this ESBL, since
this Inc plasmid types have been demonstrated to be highly
prevalent in zoonotic enterobacterial pathogens [29]. The same
animal origin reservoir is proposed for the IncI1 plasmids
harboring the blaCMY-2 gene found in E. coli avian commensal
strains [34].
It is noteworthy that ST11 and ST340 carried transferable
ESBL resistance but not resistance to carbapenems. ST(CC)11
and ST15 and ST101 are among human epidemic clones,
carrying both ESBLs and carbapenemases, which have been
increasingly detected worldwide, in Europe and in Italy in the last
years [36], [37], [38], [39], [40].
These infections are worrisome, since the antimicrobial
treatment options for these multidrug-resistant strains are very
limited. In Italy, during the last years the rapid emergence of the
carbapenemase KPC-producing KP, belonging to the ST101,
CC11, and predominantly to a single Sequence Type ST258, has
become a serious problem in health-care settings [41], [42], [43].
As for CTX-M and SHV-12 ESBLs in Italy, a high occurrence
in KP isolated from humans has been demonstrated, being the
ST15, ST37, ST147 and ST273 the prevalent clones [44], [45],
[46], [47].
In two KO isolates, the ESBL-encoding blaSHV-12 gene co-
existed with the AmpC gene blaDHA-1 in accordance with
phenotype of resistance to cefotaxime and cefoxitin observed in
the ESBL phenotypic confirmatory test. These two isolates also
carried the PMQR gene qnrB4. In these two KO transformants the
IncL/M plasmid harbored both the blaSHV-12 and the blaDHA-1
genes but not the qnrB4 gene. To our knowledge, this feature has
never been described before.
The other KO presented the blaCTX-M-9 gene, located in a
IncHI2 plasmid as described worldwide but associated to a qnrA1
gene, a feature previously described in Spain in E. coli and KP of
human origin [48], [49] and in KO in clinical specimens from
Japan [50].
Similarly to what has been observed in other human and canine
KP isolates [34], [12], the association of blaCTX-M genes with the
the aac(69)-Ib-cr encoding an aminoglycoside acetyl transferase
determining PMQR, was demonstrated in all ST101 and ST340
isolates, but only in one out of four ST15, but these PMQR genes
were not located in the same plasmid in our strains. Conversely,
PMQR encoded by different qnr genes of the qnrA or qnrB groups
were observed in all the KO isolates studied (Table 1). In the case
of the qnrA1 gene, the two KO isolates also harbored the ESBL
blaCTX-M-9 gene, a feature reported previously in association with
blaVIM-1 and IncHI2 plasmids in KO of human origin [51].
Multidrug-resistance in the ESC resistant and PMQR isolates
studied is of further concern from a therapeutic perspective, for a
possible impact on clinical outcome of affected animals. In many
isolates, the demonstration of the integrase intI1, accounts for the
presence of resistance gene cassettes with sul, aadA, cat, dfr genes,
associated with Class I integrons, similarly to what has been
described in KP of human origin [52], [53]. As for streptomycin
resistance, MIC.16 mg/L correlated in 100% isolates with the
presence of strA/B genes.
Fortunately, the absence of carbapenemases offers so far a
better scenario for antimicrobial therapy in companion animals,
although a possible circulation, within a short time, of these
carbapenemase-producing epidemic strains, is of concern also in
veterinary medicine.
In conclusion, monitoring and characterization of multidrug-
resistant Klebsiella in companion animals by means of phenotypic
and molecular methods proved to be useful for providing a picture
of mechanisms of resistance that may further spread clonally or by
horizontal gene transfer, at regional or even at international level.
Sharing this kind of information appears essential for building
awareness in companion animal therapy, also in view of
preventing and controlling the spread of multidrug-resistant
strains in veterinary hospital settings. Indeed, the bi-directional
exchange between owners and pets of Klebsiella carrying resistance
to critically important antimicrobials for human health, raise some
concerns also for the possibility of a spill back to humans,
especially at household level.
The emergence of the PMQR and, above all, the emergence of
concurrent transferable cephamycin, oxymino-cephalosporin, and
beta-lactamase inhibitor resistance in multidrug-resistant Klebsiella
isolates in pets, a recent issue even in human therapy [54], may
pose in the next future further and serious therapeutic challenges
also in bacterial infections of companion animals.
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